Icon PLC (ICLR) came out with quarterly earnings of $3.19 per share, beating the Zacks Consensus Estimate of $3.08 per share. This compares to earnings of $3.47 per share a year ago. These figures are ...

ICON PLC faces a critical test Monday when the contract research organization finally releases long-delayed fourth-quarter and full-year 2025 results, two months after an accounting investigation sent ...

Partnership will integrate ICON's clinical trial technology with Advarra's purpose-built system for research sites, embedded across a broad, deeply established global network. Partnership ...

DUBLIN--ICON plc, (Nasdaq: ICLR), a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries, announced today that it has completed a $40 ...

Is ICLR a good stock to buy? We came across a bullish thesis on ICON Public Limited Company on Value & Error’s Substack. In ...

DUBLIN--(BUSINESS WIRE)--ICON plc (NASDAQ: ICLR), a world-leading healthcare intelligence and clinical research organization, today announced that it will release its financial results for the second ...

DUBLIN--(BUSINESS WIRE)--ICON plc, (NASDAQ: ICLR) a world-leading clinical research organisation powered by healthcare intelligence, today announced that Dr. Steve Cutler, CEO of ICON plc, will ...

Orbis Investment Management released its Q4 2025 investor letter for “Orbis SICAV International Equity Fund”. The Strategy reported a positive year in 2025, with returns driven more by stock-specific ...